Discover undervalued stocks with Eulerpool.

Subscribe for $2

Getinge Stock GETI B.ST

Price

0 SEK
Today +/-
-0 SEK
Today %
-0 %

Getinge stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Getinge stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Getinge stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Getinge stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Getinge's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Getinge Stock Price History

DateGetinge Price
10/8/20250 SEK
10/7/2025213.50 SEK
10/6/2025213.98 SEK
10/3/2025211.30 SEK
10/2/2025209.22 SEK
10/1/2025203.98 SEK
9/29/2025202.50 SEK
9/26/2025201.50 SEK
9/25/2025199.45 SEK
9/24/2025209.71 SEK
9/23/2025214.28 SEK
9/22/2025211.66 SEK
9/19/2025210.86 SEK
9/18/2025211.37 SEK
9/17/2025211.22 SEK
9/16/2025211.60 SEK
9/15/2025213.02 SEK
9/12/2025213.81 SEK
9/11/2025212.50 SEK
9/10/2025212.04 SEK
9/9/2025212.30 SEK
9/8/2025210.67 SEK

Getinge Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Getinge, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Getinge from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Getinge’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Getinge. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Getinge’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Getinge’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Getinge’s growth potential.

Getinge Revenue, EBIT and net profit per share

DateGetinge RevenueGetinge EBITGetinge Net Income
2030e43.3 B SEK0 SEK5.74 B SEK
2029e45.43 B SEK6.95 B SEK4.94 B SEK
2028e43.27 B SEK6.43 B SEK4.51 B SEK
2027e39.58 B SEK5.69 B SEK4 B SEK
2026e37.69 B SEK5.16 B SEK3.53 B SEK
2025e36.06 B SEK4.6 B SEK3.16 B SEK
202434.76 B SEK4.48 B SEK1.64 B SEK
202331.83 B SEK4.15 B SEK2.41 B SEK
202228.29 B SEK3.88 B SEK2.49 B SEK
202127.05 B SEK4.47 B SEK2.97 B SEK
202029.82 B SEK4.96 B SEK3.24 B SEK
201926.56 B SEK2.7 B SEK1.22 B SEK
201824.17 B SEK-284 M SEK-967 M SEK
201722.5 B SEK2.26 B SEK1.38 B SEK
201622.17 B SEK2.68 B SEK1.19 B SEK
201530.24 B SEK3.42 B SEK1.39 B SEK

Getinge Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B SEK)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B SEK)
NET INCOME (B SEK)
NET INCOME GROWTH (%)
DIV. (SEK)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
20152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
30.2422.1722.524.1726.5629.8227.0528.2931.8334.7636.0637.6939.5843.2745.4343.3
--26.671.477.459.8812.27-9.294.6012.499.213.754.515.019.325.00-4.69
46.8446.9047.6245.7346.9049.3750.2147.4045.5447.3345.6243.6541.5638.0236.2137.99
14.1610.410.7111.0512.4614.7213.5813.4114.516.45000000
1.391.191.38-0.971.223.242.972.492.411.643.163.5344.514.945.74
--14.5315.82-170.28-226.37165.06-8.31-16.13-3.17-32.0993.1611.4413.3612.769.7016.04
2.762.761.971.501.001.503.004.004.254.404.604.144.895.535.977.00
00-28.62-23.86-33.335010033.336.253.534.55-1018.1213.097.9617.25
241.78241.78250.72272.37272.37272.37272.37272.37272.37272.37000000
- - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Getinge Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Getinge is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B SEK)
RECEIVABLES (B SEK)
OTHER REC. (B SEK)
INVENTORIES (B SEK)
OTHER CURRENT LIAB. (M SEK)
CURRENT ASSETS (B SEK)
TANGIBLE ASSETS (B SEK)
LONG-T. INVEST. (M SEK)
LONG-T. REC. (M SEK)
INTANGIBLE ASSETS (B SEK)
GOODWILL (B SEK)
OTHER NON-CURRENT ASSETS (B SEK)
NON-CURRENT ASSETS (B SEK)
TOTAL ASSETS (B SEK)
LIABILITIES
COMMON STOCK (M SEK)
ADDITIONAL PAID-IN CAPITAL (B SEK)
RETAINED EARNINGS (B SEK)
OTHER EQUITY (k SEK)
UNREAL. GAINS/LOSSES (M SEK)
EQUITY (B SEK)
LIABILITIES (B SEK)
PROVISIONS (B SEK)
OTHER SHORT-TERM LIAB. (B SEK)
SHORT-TERM DEBTS (M SEK)
LONG-TERM DEBT PORTION (B SEK)
SHORT-TERM REC. (B SEK)
LONG-T. LIAB. (B SEK)
DEFERRED TAXES (B SEK)
OTHER LIAB. (B SEK)
LONG-T. LIABILITIES (B SEK)
DEBT (B SEK)
TOTAL CAPITAL (B SEK)
2015201620172018201920202021202220232024
                   
1.631.851.71.291.276.084.085.752.762.96
7.899.036.616.977.325.855.215.956.367.27
1.320.741.11.020.90.750.730.750.720.88
5.415.434.884.544.694.514.776.236.426.59
373520273326325233283424387455
16.6217.5714.5614.1514.4917.4315.0719.1116.6518.16
4.74.312.913.164.093.974.124.875.215.7
8025120152006115
69713880325052506133
8.759.016.176.015.614.664.474.55.89.15
21.822.9916.8718.0918.6717.4319.6822.5124.8730.09
1.231.231.541.871.81.471.17110.77
36.6237.6527.5429.230.2227.5829.4932.933745.76
53.2455.2142.143.3544.7145.0144.5652.0353.6563.92
                   
119119136136136136136136136136
5.965.966.796.796.796.796.796.796.796.79
13.1214.4312.4612.2813.5714.117.8223.1123.2426.08
0000001,000000
0000000000
19.220.5119.3819.220.521.0224.7530.0430.1733.01
1.992.22.031.8721.451.922.252.362.4
2.552.71.991.962.132.72.612.352.783.34
2.922.981.982.732.793.125.276.64.946.86
0000000000
5.285.796.283.452.952.520.810.793.122.45
12.7413.6712.2710.019.869.7910.6111.9913.1915.05
16.0115.914.967.387.077.693.55.034.968.28
1.070.60.80.690.660.830.91.151.682.17
3.824.114.275.626.155.224.383.413.365.21
20.920.6310.0313.6913.8813.748.779.591015.66
33.6434.322.323.723.7423.5319.3821.5823.1830.71
52.8554.841.6842.944.2444.5544.1351.6253.3563.71
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Getinge provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Getinge's financial health and stability.

Assets

Getinge's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Getinge must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Getinge after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Getinge's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B SEK)
DEPRECIATION (B SEK)
DEFERRED TAXES (M SEK)
CHANGES IN WORKING CAPITAL (M SEK)
NON-CASH ITEM (B SEK)
PAID INTEREST (M SEK)
PAID TAXES (B SEK)
NET CASH FLOW FROM OPERATING ACTIVITIES (B SEK)
CAPITAL EXPENDITURES (M SEK)
CASH FLOW FROM INVESTING ACTIVITIES (M SEK)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M SEK)
INTEREST INCOME AND EXPENSES (M SEK)
NET DEBT CHANGE (B SEK)
NET CHANGE IN EQUITY (B SEK)
CASH FLOW FROM FINANCING ACTIVITIES (M SEK)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M SEK)
TOTAL DIVIDENDS PAID (M SEK)
NET CHANGE IN CASH FLOW (B SEK)
FREE CASH FLOW (M SEK)
SHARE-BASED COMPENSATION (M SEK)
201520162017201820192020202120222023
5.192.291.79-0.282.374.784.373.633.74
02.72.611.812.222.471.812.032.09
000000000
-1,685-1,527-1,978-887-64234249-2,255-2,456
-0.040.210.351.87-0.12-0.090.13-0.03-0.42
719617609000000
0.860.330.480.370.360.550.691.010.82
3.463.672.762.53.837.26.563.372.96
-2,054-1,607-1,663-1,380-1,220-1,045-930-1,136-1,353
-1,793-1,797-1,714-1,339-1,117-1,991-1,329-1,470-6,543
261-190-5141103-946-399-334-5,190
000000000
0.3-1.11-4.28-1.01-2.480.15-6.380.611.72
004.28000000
-422-1,749-1,169-1,440-2,772-297-7,237-500511
-2642-56-113-17-1-16-29
-691-685-1,118-424-298-433-858-1,090-1,181
-0.010.21-0.15-0.25-0.024.8-1.981.6-2.95
1,4042,0641,1001,1232,6126,1545,6302,2311,604
000000000

Getinge stock margins

The Getinge margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Getinge. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Getinge.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Getinge's sales revenue. A higher gross margin percentage indicates that the Getinge retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Getinge's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Getinge's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Getinge's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Getinge. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Getinge's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Getinge Margin History

Getinge Gross marginGetinge Profit marginGetinge EBIT marginGetinge Profit margin
2030e47.33 %0 %13.25 %
2029e47.33 %15.3 %10.88 %
2028e47.33 %14.85 %10.42 %
2027e47.33 %14.38 %10.1 %
2026e47.33 %13.69 %9.36 %
2025e47.33 %12.75 %8.78 %
202447.33 %12.9 %4.71 %
202345.54 %13.03 %7.58 %
202247.4 %13.72 %8.8 %
202150.21 %16.51 %10.98 %
202049.37 %16.64 %10.86 %
201946.9 %10.15 %4.6 %
201845.73 %-1.17 %-4 %
201747.62 %10.03 %6.12 %
201646.9 %12.08 %5.36 %
201546.84 %11.31 %4.6 %

Getinge Stock Sales Revenue, EBIT, Earnings per Share

The Getinge earnings per share therefore indicates how much revenue Getinge has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Getinge earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Getinge's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Getinge’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Getinge's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Getinge Revenue, EBIT and net profit per share

DateGetinge Sales per ShareGetinge EBIT per shareGetinge Earnings per Share
2030e158.97 SEK0 SEK21.06 SEK
2029e166.79 SEK0 SEK18.15 SEK
2028e158.85 SEK0 SEK16.55 SEK
2027e145.31 SEK0 SEK14.68 SEK
2026e138.38 SEK0 SEK12.95 SEK
2025e132.4 SEK0 SEK11.62 SEK
2024127.62 SEK16.46 SEK6.01 SEK
2023116.85 SEK15.23 SEK8.86 SEK
2022103.87 SEK14.26 SEK9.15 SEK
202199.31 SEK16.4 SEK10.9 SEK
2020109.48 SEK18.21 SEK11.89 SEK
201997.51 SEK9.9 SEK4.49 SEK
201888.75 SEK-1.04 SEK-3.55 SEK
201789.72 SEK9 SEK5.49 SEK
201691.7 SEK11.08 SEK4.91 SEK
2015125.05 SEK14.14 SEK5.75 SEK

Getinge business model

Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge is one of the most popular companies on Eulerpool.com.

Getinge SWOT Analysis

Strengths

1. Established market presence: Getinge AB is a well-known and reputable company within the medical technology industry.

2. Diverse product portfolio: The company offers a wide range of medical devices and equipment, catering to various healthcare needs.

3. Strong research and development capabilities: Getinge invests heavily in R&D, enabling them to continuously innovate and introduce new products.

Weaknesses

1. Dependence on key markets: Getinge relies heavily on certain regions for its revenue, making it vulnerable to economic fluctuations in those markets.

2. High production costs: The company's manufacturing processes can be expensive, affecting its profit margins.

3. Limited presence in emerging markets: Getinge has relatively lower market penetration in developing countries compared to its competitors.

Opportunities

1. Increasing healthcare expenditure: As global healthcare spending continues to rise, Getinge can benefit from increased demand for medical devices and equipment.

2. Growing aging population: The aging population across the world presents an opportunity for Getinge to provide specialized healthcare solutions.

3. Expansion into emerging markets: The company can focus on expanding its presence in developing countries where there is a growing demand for healthcare solutions.

Threats

1. Intense competition: Getinge operates in a highly competitive industry, facing competition from both established players and emerging startups.

2. Stringent regulatory environment: Compliance with stringent regulations can pose challenges for Getinge in terms of product development and market approvals.

3. Technological advancements: Rapid technological advancements may make existing products obsolete, requiring continuous investment in innovation.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Getinge Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Getinge historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Getinge shares outstanding

The number of shares was Getinge in 2024 — This indicates how many shares 272.37 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Getinge earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Getinge's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Getinge’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Getinge's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Getinge stock splits

In Getinge's history, there have been no stock splits.

Getinge dividend history and estimates

In 2024, Getinge paid a dividend amounting to 4.4 SEK. Dividend means that Getinge distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Getinge provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Getinge’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Getinge's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Getinge Dividend History

DateGetinge Dividend
2030e7 SEK
2029e5.97 SEK
2028e5.53 SEK
2027e4.89 SEK
2026e4.14 SEK
20254.6 SEK
20244.4 SEK
20234.25 SEK
20224 SEK
20213 SEK
20201.5 SEK
20191 SEK
20181.5 SEK
20171.97 SEK
20162.76 SEK
20152.76 SEK

Getinge dividend payout ratio

In 2024, Getinge had a payout ratio of 33.07%. The payout ratio indicates the percentage of the company's profits that Getinge distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Getinge represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Getinge could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Getinge's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Getinge Payout Ratio History

DateGetinge Payout ratio
2030e33.21 %
2029e32.9 %
2028e33.41 %
2027e33.32 %
2026e31.98 %
2025e34.92 %
202433.07 %
202327.95 %
202243.74 %
202127.51 %
202012.61 %
201922.29 %
2018-42.25 %
201735.97 %
201656.21 %
201548.01 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Getinge.

Getinge latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20251.94 SEK2.25 SEK (15.82 %)2025 Q2
3/31/20252.15 SEK2.18 SEK (1.57 %)2025 Q1
12/31/20243.66 SEK5.28 SEK (44.17 %)2024 Q4
9/30/20242.35 SEK2.24 SEK (-4.81 %)2024 Q3
6/30/20241.69 SEK2.29 SEK (35.49 %)2024 Q2
3/31/20241.47 SEK1.92 SEK (30.2 %)2024 Q1
12/31/20233.29 SEK3.11 SEK (-5.37 %)2023 Q4
9/30/20232 SEK2.66 SEK (33.18 %)2023 Q3
6/30/20230.97 SEK1.09 SEK (12.42 %)2023 Q2
3/31/20231.85 SEK2.34 SEK (26.25 %)2023 Q1
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Getinge stock

Eulerpool World ESG Rating (EESG©)

75/ 100

🌱 Environment

76

👫 Social

80

🏛️ Governance

69

Environment

Scope 1 - Direct Emissions
15,532
Scope 2 - Indirect emissions from purchased energy
3,901
Scope 3 - Indirect emissions within the value chain
614,508
Total CO₂ emissions
19,433
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees38
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Getinge shareholders

%
Name
Stocks
Change
Date
13.33956 % Bennet (Carl)36,332,96907/31/2024
7.56595 % Fjärde AP-Fonden20,607,390394,3687/31/2024
5.19185 % AMF Tjänstepension AB14,141,0412,358,5812/21/2025
5.02841 % Carnegie Fonder AB13,695,8868,529,0073/5/2025
4.35279 % Swedbank Robur Fonder AB11,855,68411,4777/31/2024
3.18666 % The Vanguard Group, Inc.8,679,504134,5747/31/2024
3.17084 % BlackRock Institutional Trust Company, N.A.8,636,408433,9517/31/2024
2.46642 % Incentive AS6,717,776945,0007/31/2024
2.45738 % Handelsbanken Kapitalförvaltning AB6,693,176-994,6347/31/2024
2.37423 % Norges Bank Investment Management (NBIM)6,466,695931,8237/31/2024
1
2
3
4
5
...
10

Getinge Executives and Management Board

Mr. Mattias Perjos

(52)
Getinge President, Chief Executive Officer, Director (since 2017)
Compensation 46.39 M SEK

Mr. Johan Malmquist

(64)
Getinge Independent Chairman of the Board (since 1997)
Compensation 1.73 M SEK

Mr. Johan Bygge

(68)
Getinge Independent Director
Compensation 972,900 SEK

Ms. Cecilia Wennborg

(61)
Getinge Independent Director
Compensation 969,795 SEK

Mr. Dan Frohm

(43)
Getinge Director
Compensation 928,395 SEK
1
2
3
4

Most common questions regarding Getinge

What values and corporate philosophy does Getinge represent?

Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.

In which countries and regions is Getinge primarily present?

Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.

What significant milestones has the company Getinge achieved?

Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.

What is the history and background of the company Getinge?

Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.

Who are the main competitors of Getinge in the market?

The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.

In which industries is Getinge primarily active?

Getinge AB is primarily active in the healthcare industry.

What is the business model of Getinge?

Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.

What is the P/E ratio of Getinge 2025?

The P/E ratio cannot be calculated for Getinge at the moment.

What is the P/S ratio of Getinge 2025?

The P/S cannot be calculated for Getinge currently.

What is the Quality Investing of Getinge?

The Quality Investing for Getinge is 2/10.

What is the revenue of Getinge 2025?

The expected Getinge revenue is 36.06 B SEK.

How high is the profit of Getinge 2025?

The expected Getinge profit is 3.16 B SEK.

What is the business model of Getinge

Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.

What is the Getinge dividend?

Getinge pays a dividend of 4 SEK distributed over 1 payouts per year.

How often does Getinge pay dividends?

Getinge pays out a dividend 1 times a year.

What is the Getinge ISIN?

The ISIN of Getinge is SE0000202624.

What is the Getinge WKN?

The WKN of Getinge is 889714.

What is the Getinge ticker?

The ticker of Getinge is GETI B.ST.

How much dividend does Getinge pay?

Over the past 12 months, Getinge paid a dividend of 4.4 SEK . This corresponds to a dividend yield of about . For the coming 12 months, Getinge is expected to pay a dividend of 4.14 SEK.

What is the dividend yield of Getinge?

The current dividend yield of Getinge is .

When does Getinge pay dividends?

Getinge pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Getinge?

Getinge paid dividends every year for the past 16 years.

What is the dividend of Getinge?

For the upcoming 12 months, dividends amounting to 4.14 SEK are expected. This corresponds to a dividend yield of 1.94 %.

In which sector is Getinge located?

Getinge is assigned to the 'Health' sector.

Wann musste ich die Aktien von Getinge kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Getinge from 4/29/2025 amounting to 4.6 SEK, you needed to have the stock in your portfolio before the ex-date on 4/23/2025.

When did Getinge pay the last dividend?

The last dividend was paid out on 4/29/2025.

What was the dividend of Getinge in the year 2024?

In the year 2024, Getinge distributed 4.25 SEK as dividends.

In which currency does Getinge pay out the dividend?

The dividends of Getinge are distributed in SEK.

All fundamentals about Getinge

Our stock analysis for Getinge Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Getinge Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.